- Home
- BMRA vs IMCC Comparison
BMRA vs IMCC Comparison
Compare BMRA & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- IMCC
- Stock Information
- Founded
- BMRA 1971
- IMCC 1980
- Country
- BMRA United States
- IMCC Israel
- Employees
- BMRA N/A
- IMCC N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- BMRA Health Care
- IMCC Health Care
- Exchange
- BMRA Nasdaq
- IMCC Nasdaq
- Market Cap
- BMRA 8.1M
- IMCC 5.3M
- IPO Year
- BMRA N/A
- IMCC N/A
- Fundamental
- Price
- BMRA $3.09
- IMCC $2.48
- Analyst Decision
- BMRA
- IMCC
- Analyst Count
- BMRA 0
- IMCC 0
- Target Price
- BMRA N/A
- IMCC N/A
- AVG Volume (30 Days)
- BMRA 26.1K
- IMCC 406.8K
- Earning Date
- BMRA 04-14-2025
- IMCC 08-13-2025
- Dividend Yield
- BMRA N/A
- IMCC N/A
- EPS Growth
- BMRA N/A
- IMCC N/A
- EPS
- BMRA N/A
- IMCC N/A
- Revenue
- BMRA $5,678,000.00
- IMCC $37,894,737.00
- Revenue This Year
- BMRA N/A
- IMCC $47.12
- Revenue Next Year
- BMRA N/A
- IMCC $12.83
- P/E Ratio
- BMRA N/A
- IMCC N/A
- Revenue Growth
- BMRA 5.01
- IMCC 12.68
- 52 Week Low
- BMRA $1.93
- IMCC $1.29
- 52 Week High
- BMRA $10.16
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- BMRA 45.39
- IMCC 47.67
- Support Level
- BMRA $3.03
- IMCC $2.67
- Resistance Level
- BMRA $3.44
- IMCC $3.35
- Average True Range (ATR)
- BMRA 0.19
- IMCC 0.40
- MACD
- BMRA 0.01
- IMCC -0.07
- Stochastic Oscillator
- BMRA 43.24
- IMCC 21.90
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.